Skip to content
akaturk Academic measurement

Academician

ABDULSAMET ERDEN

PROFESÖR

GAZİ ÜNİVERSİTESİ TIP FAKÜLTESİ DAHİLİ TIP BİLİMLERİ BÖLÜMÜ

Articles 252 YÖKSİS · 252 OpenAlex · 0
Projects 8
Books 13
Proceedings 154

YÖKSİS and OpenAlex counted separately.

Field ranking

YÖKSİS ?

Research topics

OpenAlex

Index quartiles

?
Scopus (SJR) 217
  • Q1 49
  • Q2 73
  • Q3 66
  • Q4 29
WoS (JCR) 204
  • Q1 31
  • Q2 48
  • Q3 62
  • Q4 63
TR Index TR Index

57 articles

OpenAlex citation percentile
  • Top 1% 1
  • Top 10% 11
  • Avg 63.0%
  • n 49
Other counts

Scopus (SJR)

  • Excluding abstracts 210 Q1 43 Q2 72 Q3 66 Q4 29
  • YÖKSİS rows 219

WoS (JCR)

  • Excluding abstracts 197 Q1 25 Q2 48 Q3 62 Q4 62
  • YÖKSİS rows 205

TR Index

  • YÖKSİS rows 58 articles

Articles

Articles with YÖKSİS and OpenAlex source split; narrow by quartile or TR Index.

Journals with publications

117 journals

Showing the first 80 journals (117 in total).

Article filter applied. Journal filter: Clinical and Experimental Rheumatology Clear filter

Article list

13 / 252 articles

  1. 2025 Behçets disease beyond the criteria: insights from a tertiary centre in Turkey Clinical and Experimental Rheumatology DOI 10.55563/clinexprheumatol/h8mxc6 YÖKSİS SJR Q2 JCR Q2
  2. 2025 Prevalence, incidence and geographic distribution of familial Mediterranean fever in Turkey: a national cohort study Clinical and Experimental Rheumatology DOI 10.55563/clinexprheumatol/pzbg88 YÖKSİS SJR Q2 JCR Q2
  3. 2024 Low relapse rate in patients with giant cell arteritis in a multi-centre retrospective Turkish Registry Clinical and Experimental Rheumatology DOI 10.55563/clinexprheumatol/zr7s0g YÖKSİS SJR Q2 JCR Q2
  4. 2024 Tocilizumab as a first line biologic agent in rheumatoid arthritis patients with inadequate response to disease-modifying anti-rheumatic drugs: real life experience from the TReasure Registry Clinical and Experimental Rheumatology DOI 10.55563/clinexprheumatol/2h6ma1 YÖKSİS SJR Q2 JCR Q2
  5. 2022 Comprehensive assessment and outcomes of patients with chronic periaortitis Clinical and Experimental Rheumatology DOI 10.55563/clinexprheumatol/araba3 YÖKSİS SJR Q2 JCR Q3
  6. 2022 Efficacy and safety of tofacitinib in rheumatoid arthritis-associated interstitial lung disease: TReasure real-life data Clinical and Experimental Rheumatology DOI 10.55563/clinexprheumatol/9h6dtb YÖKSİS SJR Q2 JCR Q3
  7. 2022 Clinical and laboratory factors associated with the bamboo spine in patients with axial spondyloarthritis: are there clues for the bamboo spine? Clinical and Experimental Rheumatology DOI 10.55563/clinexprheumatol/eb1zpo YÖKSİS SJR Q2 JCR Q3 OpenAlex 72.6%
  8. 2021 Biological and targeted-synthetic disease-modifying antirheumatic drugs with concomitant methotrexate or leflunomide in rheumatoid arthritis: real-life TReasure prospective data CLINICAL AND EXPERIMENTAL RHEUMATOLOGY DOI https://www.clinexprheumatol.org/abstract.asp?a=15556 YÖKSİS SJR Q1 JCR Q2
  9. 2020 Disease characteristics of psoriatic arthritis patients may differ according to age at psoriasis onset: cross-sectional data fromthe Psoriatic Arthritis-International Database CLINICAL AND EXPERIMENTAL RHEUMATOLOGY YÖKSİS SJR Q2 JCR Q2
  10. 2019 What are the main barriers to achieve minimal disease activity in psoriatic arthritis in real life? CLINICAL AND EXPERIMENTAL RHEUMATOLOGY YÖKSİS SJR Q2 JCR Q2
  11. 2018 In early arthritis patients, high HAQ at baseline and DAS28 at three months predict suboptimal outcomes at two years: a retrospective cohort study CLINICAL AND EXPERIMENTAL RHEUMATOLOGY YÖKSİS SJR Q2 JCR Q2
  12. 2018 Polyarteritis nodosa: lessons from 25 years of experience Clinical and Experimental Rheumatology DOI https://www.clinexprheumatol.org/abstract.asp?a=13024 YÖKSİS SJR Q2 JCR Q2
  13. 2018 Which definition should be used to determine colchicine resistance among patients with familial Mediterranean fever? CLINICAL AND EXPERIMENTAL RHEUMATOLOGY YÖKSİS SJR Q2 JCR Q2

Back to academicians